OverviewChartNewsTraderScreen

BNP Paribas Discount Zert ABBV 30.../  DE000PN58FF2  /

Frankfurt Zert./BNP
26/07/2024  16:20:36 Chg.-0.100 Bid16:36:11 Ask16:36:11 Underlying Strike price Expiration date Option type
116.900EUR -0.09% 117.000
Bid Size: 4,000		 117.050
Ask Size: 4,000		 AbbVie Inc - USD 30/12/2024 Call
GlobeNewswire 01/07 Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer
GlobeNewswire 01/07 OSE Immunotherapeutics Announces Publication of Preclinical Efficacy Results with Lusvertikimab in A...
GlobeNewswire 28/06 NurExone’s ExoPTEN Being Studied as Glaucoma Treatment for US$3.4 Billion Market
GlobeNewswire 28/06 Epcoritamab (TEPKINLY®) Receives Positive CHMP Opinion for the Treatment of Adults with Relapsed/ Re...
GlobeNewswire 28/06 Ensho Therapeutics Launches with Phase 2-Ready Oral α4β7 Inhibitor for Inflammatory Bowel Disease
GlobeNewswire 27/06 Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Ach...
GlobeNewswire 26/06 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 25/06 CEREVEL (NASDAQ:CERE) STOCK ALERT: Cerevel’s $45 Per Share Deal is Being Investigated by BFA Law, Sh...
GlobeNewswire 24/06 OSE Immunotherapeutics Announces Commercial and Revenue Sharing Agreement in the Field of CAR T-cell...
GlobeNewswire 22/06 CEREVEL (NASDAQ:CERE) INVESTOR ALERT: Cerevel’s $45 Per Share Offer is Being Investigated by BFA Law...
GlobeNewswire 21/06 Antibody-drug Conjugates Shift the Cancer Treatment Landscape: Novotech Whitepaper Examines Latest C...
GlobeNewswire 20/06 CEREVEL INVESTOR REMINDER: Think $45 Per Share is Too Low for Cerevel (Nasdaq:CERE)? Contact BFA Law...
GlobeNewswire 20/06 OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of I...
GlobeNewswire 19/06 OSE Immunotherapeutics Reports on its 2024 General Shareholders’ Meeting and the Evolution of the B...
GlobeNewswire 19/06 Jasper Therapeutics Announces Appointment of Svetlana Lucas Ph.D., to its Board of Directors
GlobeNewswire 18/06 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 18/06 CEREVEL STOCK UPDATE: Is $45 Per Share Enough for Cerevel (Nasdaq:CERE)? Contact BFA Law about Ongoi...
GlobeNewswire 17/06 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 17/06 Autonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, B...
GlobeNewswire 15/06 CEREVEL STOCK NOTICE: Think $45 Per Share is Too Low for Cerevel (Nasdaq: CERE)? Contact BFA Law abo...
Newsfile Corp 13/06 BioMed X Launches New US Institute in New Haven, CT
GlobeNewswire 13/06 Anima Biotech to Present at the Society for Medicines Research’s Modulating RNA with Oligonucleotide...
GlobeNewswire 13/06 LifeSci Advisors Announces Appointment of Chris Howerton Ph.D.
GlobeNewswire 13/06 CEREVEL SHAREHOLDER REMINDER: Is $45 Per Share Enough for Cerevel (Nasdaq: CERE)? BFA Law is Investi...
GlobeNewswire 13/06 What Employees at the Fortune Best Workplaces in New York, Chicago, Texas, and the Bay Area Value Mo...